Authors:
OHNISHI K
OHNO R
TOMONAGA M
KAMADA N
ONOZAWA K
KURAMOTO A
DOHY H
MIZOGUCHI H
MIYAWAKI S
TSUBAKI K
MIURA Y
OMINE M
KOBAYASHI T
NAOE T
OHSHIMA T
HIRASHIMA K
OHTAKE S
TAKAHASHI I
MORISHIMA Y
NAITO K
ASOU N
TANIMOTO M
SAKUMA A
YAMADA K
Citation: K. Ohnishi et al., A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR NEWLY-DIAGNOSED CHROMIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 86(3), 1995, pp. 906-916
Authors:
KANAMARU A
TAKEMOTO Y
TANIMOTO M
MURAKAMI H
ASOU N
KOBAYASHI T
KURIYAMA K
OHMOTO E
SAKAMAKI H
TSUBAKI K
HIRAOKA A
YAMADA O
OH H
SAITO K
MATSUDA S
MINATO K
UEDA T
OHNO R
Citation: A. Kanamaru et al., ALL-TRANS-RETINOIC ACID FOR THE TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 85(5), 1995, pp. 1202-1206
Authors:
OHNO R
OHNISHI K
TAKESHITA A
TANIMOTO M
MURAKAMI H
KANAMARU A
ASOU N
KOBAYASHI T
KURIYAMA K
OHMOTO E
SAKAMAKI H
TSUBAKI K
HIRAOKA A
YAMADA O
OH H
FURUSAWA S
MATSUDA S
NAOE T
Citation: R. Ohno et al., ALL-TRANS-RETINOIC ACID THERAPY IN RELAPSED REFRACTORY OR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN JAPAN, Leukemia, 8, 1994, pp. 64-69
Authors:
ASHIDA T
TSUBAKI K
URASE F
ISHIKAWA H
TSUJI K
HAZU S
EZUMI M
HORIUCHI A
Citation: T. Ashida et al., CHANGE OF SERUM ALPHA-1 MICROGLOBULIN AND BETA-2-MICROGLOBULIN FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 14(4), 1994, pp. 579-582
Authors:
TANIGUCHI K
TSUBAKI K
TAKE K
OKUMURA K
TERAI T
SHIOKAWA Y
Citation: K. Taniguchi et al., AGENTS FOR THE TREATMENT OF OVERACTIVE DETRUSOR .7. SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF 2,3-DIPHENYLCYCLOPENTYLAMINES AND 3,4-DIPHENYLCYCLOPENTYLAMINES, 2,3-DIPHENYL-2-CYCLOPENTENYLAMINES, AND RELATED-COMPOUNDS, Chemical and Pharmaceutical Bulletin, 42(4), 1994, pp. 896-902
Authors:
TANIGUCHI K
TSUBAKI K
MIZUNO H
TAKE K
OKUMURA K
TERAI T
SHIOKAWA Y
Citation: K. Taniguchi et al., AGENTS FOR THE TREATMENT OF OVERACTIVE DETRUSOR .6. SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF ACETAMIDE DERIVATIVES BEARING CYCLIC AMINESIN N-SUBSTITUENTS, Chemical and Pharmaceutical Bulletin, 42(1), 1994, pp. 74-84
Authors:
KURIYAMA K
TOMONAGA M
MATSUO T
KOBAYASHI T
MIWA H
SHIRAKAWA S
TANIMOTO M
ADACHI K
EMI N
HIRAOKA A
TOMINAGA N
IMAI K
ASOU N
TSUBAKI K
TAKAHASHI I
MINAMI S
YOSHIDA M
MURAKAMI H
MINATO K
OSHIMA T
FURUSAWA S
OHNO R
Citation: K. Kuriyama et al., POOR RESPONSE TO INTENSIVE CHEMOTHERAPY IN DE-NOVO ACUTE MYELOID-LEUKEMIA WITH TRILINEAGE MYELODYSPLASIA, British Journal of Haematology, 86(4), 1994, pp. 767-773
Authors:
KOBAYASHI T
MIYAWAKI S
TANIMOTO M
KURIYAMA K
MURAKAMI H
YOSHIDA M
KODERA Y
MINATO K
TSUBAKI K
OHMOTO E
OH H
JINNAI I
SAKAMAKI H
HIRAOKA A
KANAMARU A
TAKAHASHI I
FURUSAWA S
NAOE T
YAMADA O
ASOU N
NISHIKAWA K
OKABE K
OGURA M
TANAKA M
OHNO R
Citation: T. Kobayashi et al., RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 84(10), 1994, pp. 10000146-10000146
Authors:
OHNO R
TOMONAGA M
OHSHIMA T
MASAOKA T
ASOU N
OH H
NISHIKAWA K
KANAMARU A
MURAKAMI H
FURUSAWA S
HIRANO M
TSUBAKI K
IMAI K
UEDA T
KURAISHI Y
OGAWA N
Citation: R. Ohno et al., A RANDOMIZED CONTROLLED-STUDY OF GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER INTENSIVE INDUCTION AND CONSOLIDATION THERAPY IN PATIENTS WITHACUTE LYMPHOBLASTIC-LEUKEMIA, International journal of hematology, 58(1-2), 1993, pp. 73-81
Authors:
YOKOTA S
TSUBAKI K
KURIYAMA T
SHIMIZU H
IBE M
MITSUDA T
AIHARA Y
KOSUGE K
NOMAGUCHI H
Citation: S. Yokota et al., PRESENCE IN KAWASAKI-DISEASE OF ANTIBODIES TO MYCOBACTERIAL HEAT-SHOCK PROTEIN-HSP65 AND AUTOANTIBODIES TO EPITOPES OF HUMAN HSP65 COGNATE ANTIGEN, Clinical immunology and immunopathology, 67(2), 1993, pp. 163-170
Authors:
OHNO R
KOBAYASHI T
TANIMOTO M
HIRAOKA A
IMAI K
ASOU N
TOMONAGA M
TSUBAKI K
TAKAHASHI I
KODERA Y
YOSHIDA M
MURAKAMI H
NAOE T
SHIMOYAMA M
TSUKADA T
TAKEO T
TESHIMA H
ONOZAWA Y
FUJIMOTO K
KURIYAMA K
HORIUCHI A
KIMURA I
MINAMI S
MIURA Y
KAGEYAMA S
TAHARA T
MASAOKA T
SHIRAKAWA S
SAITO H
Citation: R. Ohno et al., RANDOMIZED STUDY OF INDIVIDUALIZED INDUCTION THERAPY WITH OR WITHOUT VINCRISTINE, AND OF MAINTENANCE INTENSIFICATION THERAPY BETWEEN 4 OR 12 COURSES IN ADULT ACUTE MYELOID-LEUKEMIA - AML-87 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP, Cancer, 71(12), 1993, pp. 3888-3895